State of the Art: Imaging for Myocardial Viability
Published: July 13, 2020
- Imaging for myocardial viability is an essential tool for proper utilization of invasive treatment strategies and patient prognostication. Noninvasive imaging findings identify patients at higher risk for experiencing sudden cardiac death.
- Despite lack of clinical trial evidence that viability testing leads to improved survival, it still plays an important role in clinical decision making for patients with ischemic heart disease.
- This statement considers a current knowledge about viability testing, interprets clinical trial results, and evaluates knowledge gaps.
- 2014 Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease
- 2017 Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
- 2013 Guideline for the Management of Heart Failure
- 2009 Focused Update: Guidelines for the Diagnosis and Management of Heart Failure in Adults
- Defining Quality in Cardiovascular Imaging
- Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Ischemic Heart Disease